ClinicaliQ Trial Snapshot
- Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation — Recruiting • Cardiology / Cardiovascular • NCT05920824.
- What is being tested: This prospective observational study evaluates clinical phenotypes and predictive factors for functional mitral and tricuspid regurgitation in atrial fibrillation patients, using baseline echocardiography, cardiopulmonary exercise testing echocardiography, and blood biomarkers to characterise outcomes.
- Patient eligibility overview: The trial enrolls patients with atrial fibrillation who have evidence of functional mitral and/or tricuspid regurgitation, assessed through comprehensive echocardiographic evaluation and supported by relevant blood testing.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors & outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR & TR
Eligibility Snapshot
- : * Informed consent * Age of 18 years or older * Atrial fibrillation * Moderate or severe atrial valve disease * Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.